METHODS: We assessed 87 children with OM otologically and audiologically. Medicines were prescribed, and medication compliance was ensured. The children were followed up after 3 months to judge the status of OM as resolved or recurrent. Data were statistically analyzed to derive the risk of recurrence of OM with effusion (OME) and acute OM by degree of hearing loss, type of tympanogram, age group, and sex.
RESULTS: The overall recurrence rate was 26%. The risk of recurrence was higher for OME (odds ratio [OR]=4.33; 95% confidence interval [CI]: 1.90 to 9.83); at AC auditory brainstem peak V responses up to 40 dBnHL (OR=5.20; 95% CI: 2.05 to 13), 50 dBnHL (OR=3.47; 95% CI: 0.5 to 23), and 60 dBnHL (OR=16.09; 95% CI: 4.36 to 1.2); in B (OR= 3.16; 95% CI: 1.36 to 7.33) and C tympanograms (OR=2.83; 95% CI: 0.70 to 11.41); and in the age group of 5-6 years (OR=8, 95% CI: 2.23 to 28). The risk of recurrence of OM did not differ between male and female patients.
CONCLUSIONS: The rate of recurrence was comparable to or lower than that reported in the pediatric population of other countries. The findings suggest that children with OME, severe pathology, or age of 5-6 years require more attention and frequent monitoring to minimize the risk of recurrence.
■:我们对87名OM患儿进行了耳科和听力学评估。开了药,并确保了用药依从性。3个月后对患儿进行随访,判断OM缓解或复发。对数据进行统计分析,以根据听力损失程度得出OM伴积液(OME)和急性OM复发的风险。鼓室图类型,年龄组,和性爱。
■:总复发率为26%。OME的复发风险更高(比值比[OR]=4.33;95%置信区间[CI]:1.90至9.83);在AC听觉脑干峰值V反应高达40dBnHL(OR=5.20;95%CI:2.05至13),50dBnHL(OR=3.47;95%CI:0.5至23),和60dBnHL(OR=16.09;95%CI:4.36至1.2);B(OR=3.16;95%CI:1.36至7.33)和C鼓室图(OR=2.83;95%CI:0.70至11.41);以及5-6岁年龄组(OR=8,95%CI:2.23至28)。男性和女性患者的OM复发风险没有差异。
■:复发率与其他国家儿科人群的复发率相当或更低。研究结果表明,患有OME的儿童,严重的病理学,或5-6岁的年龄需要更多的关注和频繁的监测,以尽量减少复发的风险。